Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Growth hormone antagonist and anti-cancer composition combination therapy

Growth hormone antagonist and anti-cancer composition combination therapy

US Patent 11857602 · Granted Jan 2, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating cancers using fat specific protein 27 (FSP27) compositions2025
Methods for treating cancers using fat specific protein 27 (FSP27) compositions2025
Methods for treating cancers using fat specific protein 27 (FSP27) compositions2024
Methods for treating cancers using fat specific protein 27 (FSP27) compositions2024
Methods for regulating free fatty acid flux using fat specific protein 27 (FSP272024
Peptide-based inhibitors of growth hormone action and methods of use thereof2023
Peptide-based inhibitors of growth hormone action and methods of use thereof2023
Peptide-based inhibitors of growth hormone action and methods of use thereof2022
Peptide-based inhibitors of growth hormone action and methods of use thereof2022
Method of treating cancer and method of sensitizing cancer cells to the action o2022
Method of treating cancer and method of sensitizing cancer cells to the action o2022
Therapeutic pegylated growth hormone antagonists2022